News from issuers of financial instruments admitted to trading on BSE-Sofia

News

By date From date: Search in news
By period From date: To date:
By title
By code

06-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Sopharma AD hereby informs that in the period of 01 - 05 December 2017 the company bought back on BSE-Sofia 924,732 own shares at the total value of BGN 3,948,605.64 respectively at BGN 4.27 average price per share, representing 0.686% of the share capital of the company.
The total number of treasury shares held after these transactions is 6,085,493 representing 4.51% of the share capital of the company.
The entire piece of news is posted on the financial website X3News.
06-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Donev Investments Holding AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
06-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Elpharma AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
06-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Sopharma AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
06-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Rositsa Doneva under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
06-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Elpharma AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
06-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Ognyan Donev under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.
06-12-2017 - Insider information

Company: Sopharma AD-Sofia (3JR)
Notification by Sopharma AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation) - secondary publishing.
The entire piece of news is posted on the financial website X3News.